Research and Achievement*

Research Interests

Dr. Mien-Chie Hung, Ph.D
September, 2011

BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment

Cancer Cell. 2011 Sep 13;20(3):341-56.


Dr. Yung-Luen Yu, Ph.D.
Synergistic anti-tumor activity of isochaihulactone and paclitaxel on human lung cancer cells.
J Cell Physiol. 2012 Jan;227(1):213-22.


Dr. Jen-Liang Su, Ph.D.
miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans.

J Clin Invest. 2011 Sep 1;121(9):3442-55.


Dr. Long-Yuan Li, Ph.D.
Nuclear ErbB2 enhances translation and cell growth by activating transcription of rRNA genes.
Cancer Research 71(12):4269-4279, 2011


Dr. Wei-Chien Huang, Ph.D.
Hepatitis B Virus X protein induces IKKα nuclear translocation via Akt-dependent phosphorylation to promote the motility of hepatocarcinoma cells.

Journal of Cellular Physiology (In press)


Dr. Shian-Ying Sung, Ph.D.
Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy.

Prostate. 2011 Feb 15;71(3):232-40.


Dr. Jer-Yuh Liu, Ph.D
Protein Kinase C Alpha Expression in Human Hepatocellular Carcinoma.
Adaptive Medicine 3(1): 11-15, 2011.

↑TOP